Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Usana Health Sciences (USNA) over the last 16 years, with Q3 2025 value amounting to -$0.36.

  • Usana Health Sciences' EPS (Weighted Average and Diluted) fell 16428.57% to -$0.36 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.88, marking a year-over-year decrease of 6890.46%. This contributed to the annual value of $2.19 for FY2024, which is 3348.58% down from last year.
  • As of Q3 2025, Usana Health Sciences' EPS (Weighted Average and Diluted) stood at -$0.36, which was down 16428.57% from $0.56 recorded in Q2 2025.
  • Over the past 5 years, Usana Health Sciences' EPS (Weighted Average and Diluted) peaked at $1.87 during Q3 2021, and registered a low of -$0.36 during Q3 2025.
  • In the last 5 years, Usana Health Sciences' EPS (Weighted Average and Diluted) had a median value of $0.86 in 2024 and averaged $0.9.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 4166.67% in 2021, then tumbled by 16428.57% in 2025.
  • Over the past 5 years, Usana Health Sciences' EPS (Weighted Average and Diluted) (Quarter) stood at $1.36 in 2021, then tumbled by 51.47% to $0.66 in 2022, then surged by 31.82% to $0.87 in 2023, then tumbled by 73.1% to $0.23 in 2024, then tumbled by 253.84% to -$0.36 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.36 for Q3 2025, versus $0.56 for Q2 2025 and $0.49 for Q1 2025.